Page last updated: 2024-08-26

sr141716 and glycogen

sr141716 has been researched along with glycogen in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bajzer, M; Cota, D; Foster, MT; Haas, MK; Krawczewski-Carhuatanta, KA; Magrisso, IJ; Obici, S; Olivieri, M; Pfluger, PT; Tschöp, MH	1
Herling, AW; Müller, GA; Wied, S	1

Other Studies

2 other study(ies) available for sr141716 and glycogen

Article	Year
Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice. Diabetologia, 2011, Volume: 54, Issue:12 Topics: Adipose Tissue, Brown; Animals; Body Composition; Diet, High-Fat; Energy Metabolism; Gluconeogenesis; Glucose; Glycogen; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Thermogenesis; Weight Loss	2011
Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro. Biochemistry. Biokhimiia, 2019, Volume: 84, Issue:8 Topics: Adenylate Kinase; Animals; Cell Line; Cyclic AMP; Fatty Acids; Glucose; Glycogen; Glycogenolysis; Hepatocytes; Lipid Metabolism; Liver; Male; Muscle Fibers, Skeletal; Oxidation-Reduction; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction	2019

Article

Year

Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice.

Diabetologia, 2011, Volume: 54, Issue:12

Topics: Adipose Tissue, Brown; Animals; Body Composition; Diet, High-Fat; Energy Metabolism; Gluconeogenesis; Glucose; Glycogen; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Thermogenesis; Weight Loss

2011

Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.

Biochemistry. Biokhimiia, 2019, Volume: 84, Issue:8

Topics: Adenylate Kinase; Animals; Cell Line; Cyclic AMP; Fatty Acids; Glucose; Glycogen; Glycogenolysis; Hepatocytes; Lipid Metabolism; Liver; Male; Muscle Fibers, Skeletal; Oxidation-Reduction; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction

2019